PTC Therapeutics (PTCT) had the highest return in November 2016 by a mid-cap US stock, returning 79.4%.
| ASSET | MONTH | % RETURN |
|---|---|---|
PTC Therapeutics (PTCT) | November 2016 | 79.39% |
Ionis Pharmaceuticals (IONS) | November 2016 | 66.7% |
International Seaways (INSW) | November 2016 | 65.93% |
United States Steel (X) | November 2016 | 63.24% |
Hudbay Minerals (HBM) | November 2016 | 58.82% |
Cleveland-Cliffs (CLF) | November 2016 | 55.93% |
ArcBest (ARCB) | November 2016 | 53.11% |
Chemours (CC) | November 2016 | 49.85% |
Griffon (GFF) | November 2016 | 42.69% |
SLM (SLM) | November 2016 | 41.63% |
Commercial Metals (CMC) | November 2016 | 40.14% |
Telix Pharmaceuticals Limited American Depositary Shares (TLX) | November 2016 | 37.3% |
Addus HomeCare (ADUS) | November 2016 | 36.88% |
Halozyme Therapeutics (HALO) | November 2016 | 36.22% |
ServisFirst Bancshares (SFBS) | November 2016 | 35.28% |
MACOM Technology Solutions (MTSI) | November 2016 | 34.87% |
Stride (LRN) | November 2016 | 34.68% |
TriNet (TNET) | November 2016 | 34.49% |
VSE (VSEC) | November 2016 | 34.41% |
HealthEquity (HQY) | November 2016 | 33.48% |
Transocean (RIG) | November 2016 | 32.85% |
H&E Equipment Services (HEES) | November 2016 | 32.72% |
IES (IESC) | November 2016 | 32.32% |
Terex (TEX) | November 2016 | 32.23% |
Sterling Construction (STRL) | November 2016 | 32.22% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
